Oric Pharmaceuticals (ORIC) Other Accumulated Expenses (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted Other Accumulated Expenses of $875000.0 for Q1 2026, up 1.04% on a QoQ basis from $866000.0 in Q4 2025, and down 25.6% year-over-year from $1.2 million in Q1 2025.
Oric Pharmaceuticals (ORIC) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $875000.0 for Q1 2026.
- Quarterly Other Accumulated Expenses fell 25.6% year-over-year to $875000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $875000.0 (down 25.6% YoY) and the FY2025 annual result came in at $866000.0, up 31.41% from the prior year.
- Other Accumulated Expenses was $875000.0 for Q1 2026 at Oric Pharmaceuticals, up from $866000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.2 million in Q1 2025 and bottomed at $371000.0 in Q3 2022.
- A 5-year average of $754588.2 and a median of $797000.0 in 2023 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses plunged 66.95% — and 2024, when it soared 94.77%.
- Oric Pharmaceuticals' Other Accumulated Expenses stood at $695000.0 in 2022, then increased by 14.68% to $797000.0 in 2023, then dropped by 17.31% to $659000.0 in 2024, then soared by 31.41% to $866000.0 in 2025, then advanced by 1.04% to $875000.0 in 2026.
- Business Quant data shows ORIC's Other Accumulated Expenses at $875000.0 in Q1 2026, $866000.0 in Q4 2025, and $898000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 875,000.00 |
| Dec 31, 2025 | 866,000.00 |
| Sep 30, 2025 | 898,000.00 |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 659,000.00 |
| Sep 30, 2024 | 766,000.00 |
| Jun 30, 2024 | 636,000.00 |
| Mar 31, 2024 | 894,000.00 |
| Dec 31, 2023 | 797,000.00 |
| Sep 30, 2023 | 541,000.00 |
| Jun 30, 2023 | 809,000.00 |
| Mar 31, 2023 | 459,000.00 |
| Dec 31, 2022 | 695,000.00 |
| Sep 30, 2022 | 371,000.00 |
| Jun 30, 2022 | 844,000.00 |
| Mar 31, 2022 | 435,000.00 |
| Dec 31, 2021 | 863,000.00 |
| Sep 30, 2021 | 675,000.00 |
| Jun 30, 2021 | 740,000.00 |